Cargando…
Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness
BACKGROUND: Cardiovascular disease is the leading cause of mortality among patients with serious mental illness (SMI) and the prevalence of metabolic syndrome—a constellation of cardiovascular risk factors—is significantly higher in these patients than in the general population. Metabolic monitoring...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082569/ https://www.ncbi.nlm.nih.gov/pubmed/21541294 http://dx.doi.org/10.1371/journal.pone.0019298 |
_version_ | 1782202308741824512 |
---|---|
author | Khatana, Sameed Ahmed M. Kane, Joshua Taveira, Tracey H. Bauer, Mark S. Wu, Wen-Chih |
author_facet | Khatana, Sameed Ahmed M. Kane, Joshua Taveira, Tracey H. Bauer, Mark S. Wu, Wen-Chih |
author_sort | Khatana, Sameed Ahmed M. |
collection | PubMed |
description | BACKGROUND: Cardiovascular disease is the leading cause of mortality among patients with serious mental illness (SMI) and the prevalence of metabolic syndrome—a constellation of cardiovascular risk factors—is significantly higher in these patients than in the general population. Metabolic monitoring among patients using second generation antipsychotics (SGAs)—a risk factor for metabolic syndrome—has been shown to be inadequate despite the release of several guidelines. However, patients with SMI have several factors independent of medication use that predispose them to a higher prevalence of metabolic syndrome. Our study therefore examines monitoring and prevalence of metabolic syndrome in patients with SMI, including those not using SGAs. METHODS AND FINDINGS: We retrospectively identified all patients treated at a Veterans Affairs Medical Center with diagnoses of schizophrenia, schizoaffective disorder or bipolar disorder during 2005–2006 and obtained demographic and clinical data. Incomplete monitoring of metabolic syndrome was defined as being unable to determine the status of at least one of the syndrome components. Of the 1,401 patients included (bipolar disorder: 822; schizophrenia: 222; and schizoaffective disorder: 357), 21.4% were incompletely monitored. Only 54.8% of patients who were not prescribed SGAs and did not have previous diagnoses of hypertension or hypercholesterolemia were monitored for all metabolic syndrome components compared to 92.4% of patients who had all three of these characteristics. Among patients monitored for metabolic syndrome completely, age-adjusted prevalence of the syndrome was 48.4%, with no significant difference between the three psychiatric groups. CONCLUSIONS: Only one half of patients with SMI not using SGAs or previously diagnosed with hypertension and hypercholesterolemia were completely monitored for metabolic syndrome components compared to greater than 90% of those with these characteristics. With the high prevalence of metabolic syndrome seen in this population, there appears to be a need to intensify efforts to reduce this monitoring gap. |
format | Text |
id | pubmed-3082569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30825692011-05-03 Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness Khatana, Sameed Ahmed M. Kane, Joshua Taveira, Tracey H. Bauer, Mark S. Wu, Wen-Chih PLoS One Research Article BACKGROUND: Cardiovascular disease is the leading cause of mortality among patients with serious mental illness (SMI) and the prevalence of metabolic syndrome—a constellation of cardiovascular risk factors—is significantly higher in these patients than in the general population. Metabolic monitoring among patients using second generation antipsychotics (SGAs)—a risk factor for metabolic syndrome—has been shown to be inadequate despite the release of several guidelines. However, patients with SMI have several factors independent of medication use that predispose them to a higher prevalence of metabolic syndrome. Our study therefore examines monitoring and prevalence of metabolic syndrome in patients with SMI, including those not using SGAs. METHODS AND FINDINGS: We retrospectively identified all patients treated at a Veterans Affairs Medical Center with diagnoses of schizophrenia, schizoaffective disorder or bipolar disorder during 2005–2006 and obtained demographic and clinical data. Incomplete monitoring of metabolic syndrome was defined as being unable to determine the status of at least one of the syndrome components. Of the 1,401 patients included (bipolar disorder: 822; schizophrenia: 222; and schizoaffective disorder: 357), 21.4% were incompletely monitored. Only 54.8% of patients who were not prescribed SGAs and did not have previous diagnoses of hypertension or hypercholesterolemia were monitored for all metabolic syndrome components compared to 92.4% of patients who had all three of these characteristics. Among patients monitored for metabolic syndrome completely, age-adjusted prevalence of the syndrome was 48.4%, with no significant difference between the three psychiatric groups. CONCLUSIONS: Only one half of patients with SMI not using SGAs or previously diagnosed with hypertension and hypercholesterolemia were completely monitored for metabolic syndrome components compared to greater than 90% of those with these characteristics. With the high prevalence of metabolic syndrome seen in this population, there appears to be a need to intensify efforts to reduce this monitoring gap. Public Library of Science 2011-04-26 /pmc/articles/PMC3082569/ /pubmed/21541294 http://dx.doi.org/10.1371/journal.pone.0019298 Text en This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Khatana, Sameed Ahmed M. Kane, Joshua Taveira, Tracey H. Bauer, Mark S. Wu, Wen-Chih Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness |
title | Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness |
title_full | Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness |
title_fullStr | Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness |
title_full_unstemmed | Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness |
title_short | Monitoring and Prevalence Rates of Metabolic Syndrome in Military Veterans with Serious Mental Illness |
title_sort | monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082569/ https://www.ncbi.nlm.nih.gov/pubmed/21541294 http://dx.doi.org/10.1371/journal.pone.0019298 |
work_keys_str_mv | AT khatanasameedahmedm monitoringandprevalenceratesofmetabolicsyndromeinmilitaryveteranswithseriousmentalillness AT kanejoshua monitoringandprevalenceratesofmetabolicsyndromeinmilitaryveteranswithseriousmentalillness AT taveiratraceyh monitoringandprevalenceratesofmetabolicsyndromeinmilitaryveteranswithseriousmentalillness AT bauermarks monitoringandprevalenceratesofmetabolicsyndromeinmilitaryveteranswithseriousmentalillness AT wuwenchih monitoringandprevalenceratesofmetabolicsyndromeinmilitaryveteranswithseriousmentalillness |